91 related articles for article (PubMed ID: 3937969)
1. The treatment of ovarian cancer by a multimodality approach: remission induction with chemotherapy--hexa PAMP and PAMP regimens--followed by whole-abdominal radiation.
Goldhirsch A; Greiner R; Dreher E; Locher G; Davis BW; Reinhard JP; Joss R; Brunner KW
Onkologie; 1985 Dec; 8(6):383-7. PubMed ID: 3937969
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy.
Goldhirsch A; Greiner R; Dreher E; Sessa C; Krauer F; Forni M; Jungi FW; Brunner KW; Veraguth P; Engeler V
Cancer; 1988 Jul; 62(1):40-7. PubMed ID: 3133102
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
4. Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.
Pater JL; Carmichael JA; Krepart GV; Fraser RC; Roy M; Kirk ME; Levitt M; Brown LB; Wilson KS; Shelley WE
Cancer Treat Rep; 1987 Mar; 71(3):277-81. PubMed ID: 3102056
[TBL] [Abstract][Full Text] [Related]
5. Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiation.
Buser K; Bacchi M; Goldhirsch A; Greiner R; Diener P; Sessa C; Jungi WF; Forni M; Leyvraz S; Engeler V
Ann Oncol; 1996 Jan; 7(1):65-70. PubMed ID: 9081394
[TBL] [Abstract][Full Text] [Related]
6. Pathologic data of prognostic significance for remission induction in advanced ovarian carcinoma.
Davis BW; Goldhirsch A; Locher GW; Dreher E; Greiner R; Burki K; Brunner KW
J Cancer Res Clin Oncol; 1984; 107(2):106-10. PubMed ID: 6325466
[TBL] [Abstract][Full Text] [Related]
7. [Total abdominal irradiation following combination chemotherapy and second-look laparotomy in the treatment of advanced ovarian cancer].
Greiner R; Goldhirsch A; Dreher E; Locher G; Jeanneret C; Meister A; Mihic N; Veraguth P
Onkologie; 1985 Dec; 8(6):364-72. PubMed ID: 3005937
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
[TBL] [Abstract][Full Text] [Related]
9. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
Pasmantier MW; Coleman M; Silver RT; Ballard WP
Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
[TBL] [Abstract][Full Text] [Related]
10. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.
Richman CM; Podczaski E; Weiser PA; Herbst AL
Oncology; 1986; 43(1):12-7. PubMed ID: 3079898
[TBL] [Abstract][Full Text] [Related]
11. Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group.
Wiernik PH; Yeap B; Vogl SE; Kaplan BH; Comis RL; Falkson G; Davis TE; Fazzini E; Cheuvart B; Horton J
Cancer Invest; 1992; 10(1):1-9. PubMed ID: 1735009
[TBL] [Abstract][Full Text] [Related]
12. Whole-abdomen radiation in patients with advanced ovarian carcinoma after surgery, chemotherapy, and second-look laparotomy.
Greiner R; Goldhirsch A; Davis BW; Dreher E; Peyer T; Locher G; Neuenschwander H; Joss R; Brunner K; Veraguth P
J Cancer Res Clin Oncol; 1984; 107(2):94-8. PubMed ID: 6715401
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.
Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Willemse PH; Heintz AP; van Lent M; Trimbos JB; Bouma J; Vermorken JB
J Clin Oncol; 1987 Aug; 5(8):1157-68. PubMed ID: 3114434
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinoma.
Kristensen GB; Baekelandt M; Vergote IB; Tropé C
Eur J Cancer; 1995 Oct; 31A(11):1778-80. PubMed ID: 8541099
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer.
Hartenbach EM; Harris LS; Bailey HH; Grosen EA; Larrison E; Chen D; Twiggs LB; Schink JC
Cancer J Sci Am; 1999; 5(6):348-55. PubMed ID: 10606476
[TBL] [Abstract][Full Text] [Related]
16. Modulation and intensification of a cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin ovarian cancer regimen.
Bruckner HW; Cohen CJ; Feuer E; Holland JF
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):349-56. PubMed ID: 2492648
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patients.
Brower MS; Coleman M; Pasmantier MW; Silver RT; Mamaril AP; Quiguyan CC
Med Pediatr Oncol; 1984; 12(1):17-24. PubMed ID: 6321930
[TBL] [Abstract][Full Text] [Related]
18. Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer.
Rothenberg ML; Ozols RF; Glatstein E; Steinberg SM; Reed E; Young RC
J Clin Oncol; 1992 May; 10(5):727-34. PubMed ID: 1569445
[TBL] [Abstract][Full Text] [Related]
19. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
Shapiro F; Schneider J; Markman M; Reichman BS; Venkatraman E; Barakat R; Almadrones L; Spriggs D
Gynecol Oncol; 1997 Oct; 67(1):39-45. PubMed ID: 9345354
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
Daugaard G; Hansen HH; Rørth M
Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
